Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for April 27th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 27th:

Avenue Therapeutics, Inc. (ATXI - Free Report) : This specialty pharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 28.6% over the last 60 days.    

Avenue Therapeutics’ shares gained 15.4% over the last one month above the S&P 500’s increase of 7.9%. The company possesses a Momentum Score of A.

Can-Fite BioPharma Ltd. (CANF - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.9% over the last 60 days.

Can-Fite BioPharma’s shares gained 25.9% over the last one month. The company possesses a Momentum Score of A.

Gold Fields Limited (GFI - Free Report) : This gold producer has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 45% over the last 60 days.

Gold Fields’ shares gained 41.5% over the last one month. The company possesses a Momentum Score of B.

Manning & Napier, Inc. (MN - Free Report) : This investment manager has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 41.2% over the last 60 days.

Manning & Napier’s shares gained 159.8% over the last one month. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>